Open AccessSurvival data in FDA approval for ERBITUX® (CETUXIMAB) supports use as a single agent in patients with advanced colorectal cancer
Publication year - 2007
Publication title -
cancer biology and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.166
H-Index - 113
eISSN - 1555-8576
pISSN - 1538-4047
DOI - 10.4161/cbt.6.11.5502
Subject(s) - medicine , cetuximab , irinotecan , colorectal cancer , oxaliplatin , population , oncology , clinical trial , cancer , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom